# Grünenthal GmbH clinical trials: 69 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 69 trials with Grünenthal GmbH as lead sponsor, 3 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Grünenthal GmbH: 69 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/gr-nenthal-gmbh

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 69
- Recruiting or not yet: 3
- Read on: November 19, 2026

## Trials

The 25 newest of 69, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 3, 2026 | NCT07911995 | A Trial to Investigate the Efficacy and Safety of Tegacorat in Male Participants 4 to \<7 Years of Age With Duchenne Muscular Dystrophy | Grünenthal GmbH | Phase 2 | Not yet recruiting | Duchenne Muscular Dystrophy (DMD) | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07911995) |
| September 8, 2026 | NCT07807644 | A Clinical Trial of GRT7040 in Adults With Acute Pain Following Bunionectomy | Grünenthal GmbH | Phase 2 | Not yet recruiting | Acute Pain, Bunionectomy | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07807644) |
| March 18, 2026 | NCT07479745 | Study to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of \[14C\]GRT6019 | Grünenthal GmbH | Phase 1 | Completed | Healthy Male Volunteers | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07479745) |
| January 16, 2026 | NCT07347548 | A Trial to Investigate the Safety and Pharmacokinetics of GRT6019 in Healthy Male Participants | Grünenthal GmbH | Phase 1 | Completed | Duchenne Muscular Dystrophy (DMD) | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07347548) |
| January 5, 2026 | NCT07317063 | A Trial to Investigate Safety and Pharmacokinetics of GRT6019, Including Food Effect, in Healthy Male Participants | Grünenthal GmbH | Phase 1 | Completed | Duchenne Muscular Dystrophy (DMD) | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07317063) |
| December 17, 2025 | NCT07289776 | A First-in-human Trial of GRT7041 in Healthy Participants | Grünenthal GmbH | Phase 1 | Recruiting | Treatment of Pain | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07289776) |
| July 8, 2022 | NCT05449132 | Comparison of a Single RTX-GRT7039 and Placebo Intra-articular Injection for Pain Associated With Osteoarthritis of the Knee | Grünenthal GmbH | Phase 3 | Completed | Osteoarthritis | 466 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05449132) |
| May 17, 2022 | NCT05377489 | Open-label Trial to Check the Safety and Tolerability of RTX-GRT7039 Injections for Pain Associated With Osteoarthritis of the Knee | Grünenthal GmbH | Phase 3 | Completed | Osteoarthritis | 714 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05377489) |
| February 21, 2022 | NCT05248386 | Efficacy and Safety of RTX-GRT7039 in Adult Subjects With Knee Osteoarthritis | Grünenthal GmbH | Phase 3 | Completed | Osteoarthritis | 469 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05248386) |
| July 11, 2019 | NCT04016051 | Acceptance of Clarithromycin in a Straw Compared to Syrup in Children With Upper Respiratory Tract Infections | Grünenthal GmbH | Phase 3 | Completed | Otitis Media, Tonsillitis, Pharyngitis, Bronchitis | 265 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04016051) |
| June 10, 2019 | NCT03979989 | Drug-drug Interaction Study to Evaluate the Effect of Omeprazole on CG5503 (Tapentadol) | Grünenthal GmbH | Phase 1 | Completed | Pharmacokinetic | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03979989) |
| May 20, 2019 | NCT03956134 | Pharmacokinetic Characterization of Two Novel CG5503 Tablet Formulations in Healthy Volunteers | Grünenthal GmbH | Phase 1 | Completed | Pharmacokinetics | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03956134) |
| May 16, 2019 | NCT03951987 | Investigation How CG5503 is Taken up and Excreted From the Body After 2 Minutes Intravenous Infusion With and Without Oral... | Grünenthal GmbH | Phase 1 | Completed | Pharmacokinetic | 14 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03951987) |
| May 15, 2019 | NCT03951402 | Effect of a Multiple-dose Oral Administration of CG5503 PR on the Electrical Activity of the Heart in 48 Healthy Men and Women | Grünenthal GmbH | Phase 1 | Completed | Prolonged QTc Interval, Pharmacokinetic | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03951402) |
| April 5, 2019 | NCT03905564 | A Study to Investigate Differences in the Extent and Rate of Absorption of Doxylamine/Pyridoxine From 2 Different Products Under Fasting... | Grünenthal GmbH | Phase 1 | Withdrawn | Bioavailability | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03905564) |
| December 24, 2018 | NCT03785613 | Clinical Pilot Study in Healthy Men to Characterize the Uptake of Buprenorphine Into and Its Elimination From the Body After Topical... | Grünenthal GmbH | Phase 1 | Completed | Pain | 47 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03785613) |
| December 21, 2018 | NCT03783910 | Efficacy and Safety of GRT9906 Tablets Compared to Placebo in Patients With Fibromyalgia | Grünenthal GmbH | Phase 2 | Completed | Primary Fibromyalgia | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03783910) |
| December 14, 2018 | NCT03776110 | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GRT9906 Prolonged Release Tablets After Dose Escalation in Healthy Subjects | Grünenthal GmbH | Phase 1 | Completed | Pharmacokinetics | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03776110) |
| December 10, 2018 | NCT03770234 | Clinical Study in Healthy Men to Investigate the Uptake of Buprenorphine and Its Elimination From the Body After Dermal Application as... | Grünenthal GmbH | Phase 1 | Completed | Pain, Pharmacokinetics | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03770234) |
| December 7, 2018 | NCT03768024 | A Clinical Study in Healthy Adults Who Sometimes Take Drugs for Pleasure Which Aims to Evaluate Whether GRT0151Y is Likely to be Abused | Grünenthal GmbH | Phase 1 | Completed | Pain, Acute Pain | 76 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03768024) |
| December 6, 2018 | NCT03767036 | Administration of Tramadol and Ketorolac Separately and Simultaneously to Assess a Potential Pharmacokinetic Interaction | Grünenthal GmbH | Phase 1 | Completed | Pharmacokinetics | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03767036) |
| December 6, 2018 | NCT03766984 | Pharmacokinetic Non-interaction Study With a Fixed-dose Combination Tablet With Tramadol and Diclofenac | Grünenthal GmbH | Phase 1 | Completed | Pharmacokinetics | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03766984) |
| December 5, 2018 | NCT03765801 | A Clinical Study in Healthy Women Which Aims to Explore the Intestinal Uptake of Two Different Tablets of GRTA9906 Into the Body and the... | Grünenthal GmbH | Phase 1 | Completed | Pain, Neuropathic Pain, Chronic Pain, Visceral Pain | 22 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03765801) |
| December 5, 2018 | NCT03765697 | A Study With Lidocaine 5% Medicated Plaster in Patients Suffering From Postherpetic Neuralgia | Grünenthal GmbH | Phase 3 | Completed | Post Herpetic Neuralgia | 259 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03765697) |
| December 5, 2018 | NCT03765658 | A Clinical Study in Healthy Adults Who Sometimes Take Drugs for Pleasure to Investigate the Safety and Tolerability of GRT0151Y and to Find... | Grünenthal GmbH | Phase 1 | Completed | Pain, Acute Pain, Chronic Pain | 21 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03765658) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 30 |
| Phase 2 | 11 |
| Phase 2/3 | 2 |
| Phase 3 | 23 |
| Phase 4 | 2 |
| Not applicable | 1 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 46 |
| Terminated | 16 |
| Withdrawn | 4 |
| Not yet recruiting | 2 |
| Recruiting | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Pain | 18 |
| Chronic Pain | 12 |
| Acute Pain | 11 |
| Pain, Postoperative | 9 |
| Neuralgia | 9 |
| Osteoarthritis | 6 |
| Low Back Pain | 4 |
| Muscular Dystrophy, Duchenne | 3 |
| Neoplasms | 3 |
| Complex Regional Pain Syndromes | 3 |
| Reflex Sympathetic Dystrophy | 3 |
| Agnosia | 3 |
| Osteoarthritis, Knee | 2 |
| Opioid-Related Disorders | 2 |
| Neuralgia, Postherpetic | 2 |
| Muscular Dystrophies | 1 |
| Visceral Pain | 1 |
| Wounds and Injuries | 1 |
| Lacerations | 1 |
| Surgical Wound | 1 |
| Nociceptive Pain | 1 |
| Fibromyalgia | 1 |
| Cancer Pain | 1 |
| Toothache | 1 |
| Herpes Zoster | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Glass manufacturers in the United States](https://specstream.ai/data/businesses/glass-manufacturers/united-states)
- [Metal suppliers in the United States](https://specstream.ai/data/businesses/metal-suppliers/united-states)
- [Road contractors in the United States](https://specstream.ai/data/businesses/road-contractors/united-states)
- [Wholesale grocers in the United States](https://specstream.ai/data/businesses/wholesale-grocers/united-states)
- [Business management services in the United States](https://specstream.ai/data/businesses/business-management-services/united-states)
- [Event technology companies in the United States](https://specstream.ai/data/businesses/event-technology-companies/united-states)
